Islatravir: A potential PrEP & HIV drug now being tested

A new antiretroviral named islatravir is showing promise for HIV treatment, and for PrEP delivered through an under-the-skin implant.

There are many options for trans people interested in having a baby. Two reproductive health specialists answer questions that trans people may have about fertility, hormones and pregnancy.

Dr. Neal Sheran shares information about long-acting HIV medications currently being studied—including who might benefit from them, and some outstanding concerns from the medical community.

Harm reduction activist Laura Thomas joins SFAF and plans to get you involved to advance policies to improve the health of people who use drugs.

San Francisco AIDS Foundation condemns the practice of separating parents or guardians from their children at the border, especially people living with HIV.

Erin Wilson, DrPH, MPH shares research conducted with trans women in San Francisco, and explains why simply providing accessible gender-affirming services and HIV prevention and care isn’t enough to offset inequities.

In a sample of more than 2,500 transgender clients receiving care from a large managed health care system, only 16% with an indication for PrEP were linked to PrEP care.

New research presented at IAS 2019 showed the effectiveness of a counseling intervention to improve mood, reduce substance use, and lower viral loads in men using meth.